"Designing Growth Strategies is in our DNA"

U.S. Inflammatory Bowel Disease Treatment Market Size, Share & COVID-19 Impact Analysis, By Disease Indication (Ulcerative Colitis and Crohns Disease), By Route of Administration (Oral and Injectables), By Drug Class (IL Inhibitors, TNF Inhibitors, Anti-integrin, JAK Inhibitors, Corticosteroids, ASA Drugs, and Others), By Distribution Channel (Hospital Pharmacy and Retail Pharmacy & Other), and Country Forecast, 2023-2030

Last Updated: November 04, 2024 | Format: PDF | Report ID: FBI108774

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Request Sample PDF

man icon
Mail icon
Captcha refresh
  • 2019-2030
  • 2022
  • 2019-2021
  • 80






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X